Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

ACORDA THERAPEUTICS, INC.

(ACOR)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su ACORDA THERAPEUTICS, INC.
21/09ACORDA THERAPEUTICS: Termination of Material Definitive Agreement (Form 8-K)
21/09ACORDA THERAPEUTICS INC: Termination of a Material Definitive Agreement (form 8-K)
09/09ACORDA THERAPEUTICS: to Cut 15% of Staff; Names Chief Operating Officer, Chief Commercial..
09/09ACORDA THERAPEUTICS: Announces Corporate Restructuring, Management Changes (Form 8-K)
09/09ACORDA THERAPEUTICS INC: Costs Associated with Exit or Disposal Activities, Change in Dir..
09/09Acorda Therapeutics, Inc. Announces Executive Changes
09/09Acorda Therapeutics, Inc. Announces Executive Changes
09/09ACORDA THERAPEUTICS: Announces Corporate Restructuring, Management Changes
09/09Acorda Therapeutics Announces Management Changes
23/08ACORDA THERAPEUTICS INC: Change in Directors or Principal Officers (form 8-K)
23/08Acorda Therapeutics, Inc. Announces Board Resignations
12/08ACORDA THERAPEUTICS: Management's Discussion and Analysis of Financial Condition and Resu..
05/08ACORDA: Q2 Earnings Snapshot
05/08ACORDA THERAPEUTICS: Earnings Flash (ACOR) ACORDA THERAPEUTICS Posts Q2 Revenue $31.8M
05/08ACORDA THERAPEUTICS INC: Results of Operations and Financial Condition, Financial Stateme..
05/08ACORDA THERAPEUTICS: Reports Second Quarter 2021 Financial Results
05/08Acorda Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30..
05/08Acorda Therapeutics, Inc. Provides Earnings Guidance for the Fiscal 2021
03/08Assembly Biosciences Names New COO, CFO
30/07ACORDA SECOND QUARTER 2021 UPDATE: Webcast/Conference Call Scheduled for August 5, 2021
23/07ACORDA THERAPEUTICS: Announces Agreement to Commercialize INBRIJA® in Spain (Form 8-K)
23/07ACORDA THERAPEUTICS INC: Other Events, Financial Statements and Exhibits (form 8-K)
23/07ACORDA THERAPEUTICS: Signs Deal With Esteve Pharmaceuticals for Commercialization of Inbr..
22/07ACORDA THERAPEUTICS: Announces Agreement to Commercialize INBRIJA® in Spain
22/07Acorda Therapeutics, Inc. Enters into Distribution and Supply Agreements with Esteve Ph..
18/06NORTH AMERICAN MORNING BRIEFING: Dow on Track for -2-
16/06ACORDA THERAPEUTICS: Repays $69 Million in Outstanding Convertible Senior Notes Due 2021
16/06ACORDA THERAPEUTICS INC: Other Events, Financial Statements and Exhibits (form 8-K)
16/06ACORDA THERAPEUTICS: Announces Repayment of Convertible Senior Notes (Form 8-K)
16/06ACORDA THERAPEUTICS: Announces Repayment of Convertible Senior Notes
04/06ACORDA THERAPEUTICS INC: Submission of Matters to a Vote of Security Holders (form 8-K)
02/06ACORDA THERAPEUTICS INC: Other Events, Financial Statements and Exhibits (form 8-K)
12/05ACORDA THERAPEUTICS: Management's Discussion and Analysis of Financial Condition and Resu..
07/05LEVÉE DES BREVETS SUR LES VACCINS: pour les laboratoires, la peur d'un précédent
06/05ACORDA THERAPEUTICS: Provides Financial and Business Update for First Quarter 2021
06/05ACORDA THERAPEUTICS INC: Results of Operations and Financial Condition, Financial Stateme..
06/05ACORDA: Q1 Earnings Snapshot
06/05ACORDA THERAPEUTICS: Earnings Flash (ACOR) ACORDA THERAPEUTICS Posts Q1 Revenue $28.9M
06/05ACORDA THERAPEUTICS: Reports First Quarter 2021 Financial Results
06/05Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31..
06/05Acorda Therapeutics, Inc. Provides Financial Guidance for the Full Year of 2021
23/04ACORDA THERAPEUTICS: 2021 Proxy Statement (PDF 1.18 MB)
13/04ACORDA THERAPEUTICS: Celebrity Chef Zarela Martinez Partners with Acorda Therapeutics on ..
12/04ACORDA THERAPEUTICS: Celebrity Chef Zarela Martinez Partners with Acorda Therapeutics on ..
16/03ACORDA THERAPEUTICS: Management's Discussion and Analysis of Financial Condition and Resu..
08/03ACORDA THERAPEUTICS: to Present at H.C. Wainwright Global Life Sciences Virtual Conferenc..
04/03ACORDA THERAPEUTICS: Provides Financial and Business Update for Fourth Quarter 2020
04/03ACORDA: Q4 Earnings Snapshot
04/03ACORDA THERAPEUTICS': Q4 Net Loss Widens to $2.50 Per Share, Lagging Street Views; Revenu..
04/03ACORDA THERAPEUTICS INC: Results of Operations and Financial Condition, Financial Stateme..
04/03ACORDA THERAPEUTICS: Earnings Flash (ACOR) ACORDA THERAPEUTICS Reports Q4 Revenue $38.2M
04/03Acorda Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended Decembe..
25/02ACORDA FOURTH QUARTER/YEAR END 2020 : Webcast/Conference Call Scheduled for March 4, 2021
19/02ACORDA THERAPEUTICS INC: Change in Directors or Principal Officers, Financial Statements ..
19/02ACORDA THERAPEUTICS: Announces Departure of Chief, Business Operations
19/02Acorda Therapeutics Announces Executive Changes
17/02ACORDA THERAPEUTICS INC: Completion of Acquisition or Disposition of Assets, Other Events..
11/02ACORDA THERAPEUTICS: Announces Completion of Sale of Manufacturing Operations to Catalent
11/02Acorda Therapeutics Announces Completion of Sale of Manufacturing Operations to Catalen..
10/02Catalent Pharma Solutions, Inc. completed the acquisition of INBRIJA Manufacturing Oper..
20/01ACORDA THERAPEUTICS INC: Other Events (form 8-K)
13/01ACORDA THERAPEUTICS: Wedbush Backs Acorda Therapeutics' Chelsea Facility Sale, Warns of J..
13/01MIDDAY REPORT: Wall Street Mixed Midday, Intel Soars On Chief Executive Change
13/01ACORDA THERAPEUTICS: to Sell Inbrija Manufacturing Operations in Massachusetts to Catalen..
13/01Wall Street Sees Cautiously Lower Open, Trump Impeachment Vote in Focus
13/01ACORDA THERAPEUTICS INC: Entry into a Material Definitive Agreement, Results of Operation..
13/01ACORDA THERAPEUTICS: Announces Agreement for Sale of Manufacturing Operations and Long-Te..
13/01Acorda Therapeutics, Inc. Provides Earnings Guidance for the Full Year 2021
13/01Acorda Therapeutics, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Ye..
13/01Catalent Pharma Solutions, Inc. entered into an asset purchase agreement to acquire INB..
12/01ACORDA THERAPEUTICS: to Present at 39th Annual J.P. Morgan Health Care Conference
11/01ACORDA THERAPEUTICS: to Present at H.C. Wainwright BIOCONNECT Virtual Conference
04/01CLOSE UPDATE: Stocks End Lower Amid OPEC+ Output Decision Delay, Ahead of Georgia Runoff ..
04/01MIDDAY REPORT: Wall Street Slides Midday as Markets Kick Off 2021
2020ACORDA THERAPEUTICS: Completes 1-for-6 Reverse Stock Split
1  2  3  4  5  6  7  8  9  10Pross.
Prossimo evento su ACORDA THERAPEUTICS, INC.
03/11/21